Myriad Genetics, Inc.

Myriad Genetics, Inc.verified

MYGN

Price:

$4.33

Market Cap:

$408.96M

Myriad Genetics, Inc. is a leading company specializing in genetic testing and precision medicine. The firm focuses on developing and marketing a wide array of genetic diagnostic solutions across both domestic U.S. and international landscapes. Their extensive diagnostic offerings cater to crucial medical fields, including oncology, women's health, and mental well-being. In cancer diagnostics, Myriad provides several sophisticated molecular tests. These include the MyRisk Hereditary Cancer Test, which uses DNA sequencing to evaluate an individual's susceptibility to inherited cancer types. The BRACAnalysis CDx functions as a vital companion diagnostic, leveraging DNA sequencing to inform tre...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

1995-10-06

Stock Exchange

NASDAQ

Ticker

MYGN

The Enterprise Value as of June 2026 (TTM) for Myriad Genetics, Inc. (MYGN) is 496.06M

According to Myriad Genetics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 496.06M. This represents a change of -19.15% compared to the average of 613.53M of the last 4 quarters.

Myriad Genetics, Inc. (MYGN) Historical Enterprise Value (quarterly & annually)

How has MYGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Myriad Genetics, Inc. over the last ten years is 1.58B. The current 496.06M Enterprise Value has changed 3.04% with respect to the historical average. Over the past ten years (40 quarters), MYGN's Enterprise Value was at its highest in in the September 2018 quarter at 3.29B. The Enterprise Value was at its lowest in in the March 2026 quarter at 508.75M.

Quarterly (TTM)
Annual

Average

1.58B

Median

1.63B

Minimum

634.00M

Maximum

2.49B

Myriad Genetics, Inc. (MYGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Myriad Genetics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 67.75%

Maximum Annual Enterprise Value = 2.49B

Minimum Annual Increase = -54.51%

Minimum Annual Enterprise Value = 634.00M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025634.00M-50.47%
20241.28B-20.24%
20231.60B27.64%
20221.26B-36.46%
20211.98B20.02%
20201.65B67.75%
2020982.86M-54.51%
20192.16B-13.29%
20182.49B41.46%
20171.76B-15.04%

Myriad Genetics, Inc. (MYGN) Average Enterprise Value

How has MYGN Enterprise Value performed in the past?

The current Enterprise Value of Myriad Genetics, Inc. (MYGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.17B

5-year avg

1.35B

10-year avg

1.58B

Myriad Genetics, Inc. (MYGN) Enterprise Value vs. Peers

How is MYGN’s Enterprise Value compared to its peers?

Myriad Genetics, Inc.’s Enterprise Value is less than Castle Biosciences, Inc. (600.79M), less than Personalis, Inc. (816.82M), less than CareDx, Inc (1.13B), less than Fulgent Genetics, Inc. (517.29M), greater than DarioHealth Corp. (63.18M), less than AMN Healthcare Services, Inc. (1.41B), less than Vir Biotechnology, Inc. (1.26B), less than Evolent Health, Inc. (1.36B), less than Maravai LifeSciences Holdings, Inc. (2.49B), less than Ginkgo Bioworks Holdings, Inc. (782.25M),

Build a custom stock screener for Myriad Genetics, Inc. (MYGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Myriad Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Myriad Genetics, Inc. (MYGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Myriad Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Myriad Genetics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Myriad Genetics, Inc. (MYGN)?

What is the 3-year average Enterprise Value for Myriad Genetics, Inc. (MYGN)?

What is the 5-year average Enterprise Value for Myriad Genetics, Inc. (MYGN)?

How does the current Enterprise Value for Myriad Genetics, Inc. (MYGN) compare to its historical average?